MaxCyte (MXCT) director buys 50,000 shares at $1.29 — Form 4

Brooke William W, a director of MaxCyte, Inc. (MXCT), reported a purchase of 50,000 shares of common stock on 08/13/2025 at $1.29 per share, bringing his direct beneficial ownership to 150,879 shares.

Accepted by SEC EDGAR 08/13/2025 - 07:45 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Brooke William W, a director of MaxCyte, Inc. (MXCT), reported a purchase of 50,000 shares of common stock on 08/13/2025 at $1.29 per share, bringing his direct beneficial ownership to 150,879 shares. The Form 4 shows no derivative holdings and no amendment date. The filing was signed by an attorney-in-fact, David Sandoval, on 08/13/2025.

Insights

Securities Analyst

TL;DR: Insider purchase of 50,000 shares at $1.29 increases direct holdings to 150,879; disclosure is routine.

The reported purchase is a straightforward Form 4 disclosure showing a P (purchase) on 08/13/2025 for 50,000 common shares at $1.29. The increase in direct beneficial ownership to 150,879 shares is clearly stated. No derivatives or amendments are reported, so this filing simply documents the insider acquisition without additional complexity.

Corporate Governance Expert

TL;DR: Director-level insider purchase disclosed and properly signed by an attorney-in-fact; filing contains no material anomalies.

The reporting person is identified as a director and the Form 4 is signed by an attorney-in-fact, David Sandoval, on the transaction date. The form lists the transaction as a purchase and records resulting direct ownership. There are no amendment dates or derivative entries that would indicate additional governance issues.

Insider Trade Summary

Net Buyer: 50,000 shares

Net Buy 1 txn

Insider Brooke William W

Role Director

Bought 50,000 shs ($65K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	50,000	$1.29	$65K

Holdings After Transaction: Common Stock — 150,879 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brooke William W

(Last) (First) (Middle)

C/O MAXCYTE, INC.

9713 KEY WEST AVENUE, SUITE 400

(Street)

ROCKVILLE MD 20850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXCYTE, INC. [ MXCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		P		50,000	A	$1.29	150,879	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ David Sandoval, Attorney-in-Fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.